Pub Date : 2024-02-04DOI: 10.1177/26324636231226041
Sudipta Mondal, Dinesh P Raja, Jyothi Vijay
Pacemaker bigeminy is not an uncommon electrocardiographic finding in device clinics. However, such a pattern mandates the differentiation of important possible diagnostic considerations such as premature atrial contractions, oversensing the T wave or the QRS complex, dual AV nodal physiology, and retrograde atrial depolarization. We present a case of pacemaker bigeminy where ventricular pacing was used to exclude the truncated form of pacemaker-mediated tachycardia and reach a diagnosis of atrial bigeminy, which was crucial from the management’s perspective.
{"title":"Ventricular Pacing in Pacemaker Bigeminy to Rule in/out Truncated Pacemaker-mediated Tachycardia","authors":"Sudipta Mondal, Dinesh P Raja, Jyothi Vijay","doi":"10.1177/26324636231226041","DOIUrl":"https://doi.org/10.1177/26324636231226041","url":null,"abstract":"Pacemaker bigeminy is not an uncommon electrocardiographic finding in device clinics. However, such a pattern mandates the differentiation of important possible diagnostic considerations such as premature atrial contractions, oversensing the T wave or the QRS complex, dual AV nodal physiology, and retrograde atrial depolarization. We present a case of pacemaker bigeminy where ventricular pacing was used to exclude the truncated form of pacemaker-mediated tachycardia and reach a diagnosis of atrial bigeminy, which was crucial from the management’s perspective.","PeriodicalId":429933,"journal":{"name":"Indian Journal of Clinical Cardiology","volume":"49 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139866828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-04DOI: 10.1177/26324636241227024
A. Matthias, Anthony Nilesh Ranjeev Fernandopulle
A 35-year-old patient found to have tuberous xanthomas was diagnosed to have familial hypercholesterolemia (FH). Dermatological manifestations can trigger the diagnosis of FH.
{"title":"Tuberous Xanthoma: A Clue to the Diagnosis of Familial Hypercholesterolemia","authors":"A. Matthias, Anthony Nilesh Ranjeev Fernandopulle","doi":"10.1177/26324636241227024","DOIUrl":"https://doi.org/10.1177/26324636241227024","url":null,"abstract":"A 35-year-old patient found to have tuberous xanthomas was diagnosed to have familial hypercholesterolemia (FH). Dermatological manifestations can trigger the diagnosis of FH.","PeriodicalId":429933,"journal":{"name":"Indian Journal of Clinical Cardiology","volume":"27 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139866231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-03DOI: 10.1177/26324636231221043
Amar N. Patnaik
{"title":"New Hope for Secondary Prevention of Coronary Disease","authors":"Amar N. Patnaik","doi":"10.1177/26324636231221043","DOIUrl":"https://doi.org/10.1177/26324636231221043","url":null,"abstract":"","PeriodicalId":429933,"journal":{"name":"Indian Journal of Clinical Cardiology","volume":"2 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139683235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-03DOI: 10.1177/26324636241227050
Sudipta Mondal, Saurav Banerjee
Acute promyelocytic leukemia (APML) is a myeloid leukemia classified as M3-AML. It is known for its bleeding diathesis, which is predominantly driven by disseminated intravascular coagulation and primary hyperfibrinolysis. However, thrombotic events are relatively less common. A combination of bleeding and thrombotic events is rare and poses a challenge in management. We present a case of acute promyelocytic leukemia complicated by deep venous thrombosis, pulmonary thromboembolism, and hematemesis.
{"title":"Acute Promyelocytic Leukemia Complicated by Deep Venous Thrombosis, Pulmonary Thromboembolism, and Hematemesis","authors":"Sudipta Mondal, Saurav Banerjee","doi":"10.1177/26324636241227050","DOIUrl":"https://doi.org/10.1177/26324636241227050","url":null,"abstract":"Acute promyelocytic leukemia (APML) is a myeloid leukemia classified as M3-AML. It is known for its bleeding diathesis, which is predominantly driven by disseminated intravascular coagulation and primary hyperfibrinolysis. However, thrombotic events are relatively less common. A combination of bleeding and thrombotic events is rare and poses a challenge in management. We present a case of acute promyelocytic leukemia complicated by deep venous thrombosis, pulmonary thromboembolism, and hematemesis.","PeriodicalId":429933,"journal":{"name":"Indian Journal of Clinical Cardiology","volume":"21 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139868033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-03DOI: 10.1177/26324636231225331
S. Paidi, Mounika Chintada
For mitral valve pathologies like mitral stenosis and mitral regurgitation various treatment options are currently available. However, in patients who have previously operated on mitral valves only a few options are applicable. In this case report, we provide detailed insight into transcatheter mitral valve-in-valve implant in a patient with a degenerated surgically implanted mitral bioprosthetic valve.
{"title":"Transcatheter Mitral Valve-in-valve Implantation with the Balloon-expandable Myval Device","authors":"S. Paidi, Mounika Chintada","doi":"10.1177/26324636231225331","DOIUrl":"https://doi.org/10.1177/26324636231225331","url":null,"abstract":"For mitral valve pathologies like mitral stenosis and mitral regurgitation various treatment options are currently available. However, in patients who have previously operated on mitral valves only a few options are applicable. In this case report, we provide detailed insight into transcatheter mitral valve-in-valve implant in a patient with a degenerated surgically implanted mitral bioprosthetic valve.","PeriodicalId":429933,"journal":{"name":"Indian Journal of Clinical Cardiology","volume":"18 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139868304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-03DOI: 10.1177/26324636231225331
S. Paidi, Mounika Chintada
For mitral valve pathologies like mitral stenosis and mitral regurgitation various treatment options are currently available. However, in patients who have previously operated on mitral valves only a few options are applicable. In this case report, we provide detailed insight into transcatheter mitral valve-in-valve implant in a patient with a degenerated surgically implanted mitral bioprosthetic valve.
{"title":"Transcatheter Mitral Valve-in-valve Implantation with the Balloon-expandable Myval Device","authors":"S. Paidi, Mounika Chintada","doi":"10.1177/26324636231225331","DOIUrl":"https://doi.org/10.1177/26324636231225331","url":null,"abstract":"For mitral valve pathologies like mitral stenosis and mitral regurgitation various treatment options are currently available. However, in patients who have previously operated on mitral valves only a few options are applicable. In this case report, we provide detailed insight into transcatheter mitral valve-in-valve implant in a patient with a degenerated surgically implanted mitral bioprosthetic valve.","PeriodicalId":429933,"journal":{"name":"Indian Journal of Clinical Cardiology","volume":"67 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139808294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-03DOI: 10.1177/26324636231217658
K. Parvathareddy
{"title":"Present-day Training in DM/DrNB Cardiology: Does It Need a Revamp?","authors":"K. Parvathareddy","doi":"10.1177/26324636231217658","DOIUrl":"https://doi.org/10.1177/26324636231217658","url":null,"abstract":"","PeriodicalId":429933,"journal":{"name":"Indian Journal of Clinical Cardiology","volume":"246 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139807907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-03DOI: 10.1177/26324636231223325
T. Ilodibia, Clement O. Odigwe, Augustine O. Odili
Introduction: QRS voltages for electrocardiographic left ventricular hypertrophy (ECG-LVH) are more prominent in Black athletes than non-Black athletes. The underlying physiological relationships of ECG-LVH in BA remain enigmatic despite their greater predisposition to arterial hypertension. Objectives: To determine the frequency of eight eponymous ECG-LVH criteria in male collegiate athletes in Nigeria; To determine the diagnostic performance of the most prevalent criteria; To determine the predictors of ECG-LVH. Methods: 34 (thirty-four) athletes and 49 (forty-nine) non-athletic controls with normal electrocardiograms and echocardiograms were retrospectively recruited from an existing pre-participation screening cohort. They were all normotensive, non-obese and normoglycemic, and matched for age and body mass index (BMI). Results: The four most frequent criteria were Sokolow-Lyon index (67.6% vs. 36.7%; χ 2 = 7.7; p = .006), Romhilt’s criterion (52.9% vs. 8.2%; χ 2 = 20.6; p < .001), Peguero-Lo Presti criterion (38.2% vs. 22.4%; χ 2 = 2.43; p < .144), and Mazzoleni’s criterion (35.3% vs. 4.1%; χ 2 = 13.95; p < .001). The sensitivity, specificity and accuracy of these criteria ranged between 23.8%–57.1%, 38.5%–53.9%, and 32.4%–50.0%, respectively. Athletic activity (OR = 4.49; 95% confidence interval, CI = 1.63–12.36; p = .004) and lower BMI (OR = 0.78; 95% CI = 0.63–0.97; p = .026) were independent predictors of ECG-LVH by the Sokolow-Lyon criterion. Conclusions: Voltage ECG-LVH criteria all poorly predict the presence of echocardiographic LVH in young male Black athletes. However, the Sokolow-Lyon criterion seems to be associated with a benign cardio-metabolic profile in such athletes and appears hypothetically superior to other voltage criteria for identifying physiological cardiac remodeling in them. This hypothesis should be tested in future studies.
{"title":"Prevalence, Performance and Predictors of Electrocardiographic Left Ventricular Hypertrophy in Male Black Athletes: A Retrospective Study","authors":"T. Ilodibia, Clement O. Odigwe, Augustine O. Odili","doi":"10.1177/26324636231223325","DOIUrl":"https://doi.org/10.1177/26324636231223325","url":null,"abstract":"Introduction: QRS voltages for electrocardiographic left ventricular hypertrophy (ECG-LVH) are more prominent in Black athletes than non-Black athletes. The underlying physiological relationships of ECG-LVH in BA remain enigmatic despite their greater predisposition to arterial hypertension. Objectives: To determine the frequency of eight eponymous ECG-LVH criteria in male collegiate athletes in Nigeria; To determine the diagnostic performance of the most prevalent criteria; To determine the predictors of ECG-LVH. Methods: 34 (thirty-four) athletes and 49 (forty-nine) non-athletic controls with normal electrocardiograms and echocardiograms were retrospectively recruited from an existing pre-participation screening cohort. They were all normotensive, non-obese and normoglycemic, and matched for age and body mass index (BMI). Results: The four most frequent criteria were Sokolow-Lyon index (67.6% vs. 36.7%; χ 2 = 7.7; p = .006), Romhilt’s criterion (52.9% vs. 8.2%; χ 2 = 20.6; p < .001), Peguero-Lo Presti criterion (38.2% vs. 22.4%; χ 2 = 2.43; p < .144), and Mazzoleni’s criterion (35.3% vs. 4.1%; χ 2 = 13.95; p < .001). The sensitivity, specificity and accuracy of these criteria ranged between 23.8%–57.1%, 38.5%–53.9%, and 32.4%–50.0%, respectively. Athletic activity (OR = 4.49; 95% confidence interval, CI = 1.63–12.36; p = .004) and lower BMI (OR = 0.78; 95% CI = 0.63–0.97; p = .026) were independent predictors of ECG-LVH by the Sokolow-Lyon criterion. Conclusions: Voltage ECG-LVH criteria all poorly predict the presence of echocardiographic LVH in young male Black athletes. However, the Sokolow-Lyon criterion seems to be associated with a benign cardio-metabolic profile in such athletes and appears hypothetically superior to other voltage criteria for identifying physiological cardiac remodeling in them. This hypothesis should be tested in future studies.","PeriodicalId":429933,"journal":{"name":"Indian Journal of Clinical Cardiology","volume":"290 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139808055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-03DOI: 10.1177/26324636231217658
K. Parvathareddy
{"title":"Present-day Training in DM/DrNB Cardiology: Does It Need a Revamp?","authors":"K. Parvathareddy","doi":"10.1177/26324636231217658","DOIUrl":"https://doi.org/10.1177/26324636231217658","url":null,"abstract":"","PeriodicalId":429933,"journal":{"name":"Indian Journal of Clinical Cardiology","volume":"37 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139867652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-03DOI: 10.1177/26324636231226031
Tammiraju Iragavarapu
Beta blockers (BBs) are widely acknowledged as a standard care for numerous cardiovascular conditions. They have a long-established history in treating angina, regulating heart rate in atrial fibrillation and ventricular tachycardia, and managing heart failure with reduced ejection fraction (HFREF). The effectiveness of BBs in treating acute coronary syndrome was established during a time when reperfusion therapies were not readily available. However, with the recent advancements in coronary revascularization techniques, the role of BB therapy in managing patients after a myocardial infarction and in those with stable angina has become a subject of debate. Likewise, there are uncertainties about the efficacy of BBs in individuals with HFREF who also suffer from atrial fibrillation, as well as in patients with heart failure with preserved ejection fraction (HFPEF). Furthermore, there are numerous concerns about using BBs as the initial therapy, as was customary in hypertension management in the past, and safety concerns regarding their use in patients undergoing non-cardiac surgery. This comprehensive review aims to thoroughly examine all existing recent evidence concerning BB therapy in various cardiovascular scenarios and to provide a valuable guidance to the clinicians in the field of cardiology.
{"title":"Beta Blockers—Still the Best Option or an Obligation!","authors":"Tammiraju Iragavarapu","doi":"10.1177/26324636231226031","DOIUrl":"https://doi.org/10.1177/26324636231226031","url":null,"abstract":"Beta blockers (BBs) are widely acknowledged as a standard care for numerous cardiovascular conditions. They have a long-established history in treating angina, regulating heart rate in atrial fibrillation and ventricular tachycardia, and managing heart failure with reduced ejection fraction (HFREF). The effectiveness of BBs in treating acute coronary syndrome was established during a time when reperfusion therapies were not readily available. However, with the recent advancements in coronary revascularization techniques, the role of BB therapy in managing patients after a myocardial infarction and in those with stable angina has become a subject of debate. Likewise, there are uncertainties about the efficacy of BBs in individuals with HFREF who also suffer from atrial fibrillation, as well as in patients with heart failure with preserved ejection fraction (HFPEF). Furthermore, there are numerous concerns about using BBs as the initial therapy, as was customary in hypertension management in the past, and safety concerns regarding their use in patients undergoing non-cardiac surgery. This comprehensive review aims to thoroughly examine all existing recent evidence concerning BB therapy in various cardiovascular scenarios and to provide a valuable guidance to the clinicians in the field of cardiology.","PeriodicalId":429933,"journal":{"name":"Indian Journal of Clinical Cardiology","volume":"13 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139867607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：